CSE: HAVN
OTC: HAVLF
FRA: 5NP
Get Notified
Edit Content
Main Menu
CSE: HAVN
OTC: HAVLF
FRA: 5NP

clinical trial

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder

Leave a Comment / Education, Health & Performance, Psychedelics / By

Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and …

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder Read More »

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness

Leave a Comment / Education, Health & Performance, Plant Medicines, Psychedelics / By

By Raley Anne James According to a mental health organization, one in five adults in the U.S. experience having a mental illness each year. These include serious mental health conditions such as anxiety disorders, major depressive episodes, and post-traumatic stress disorder. Despite the various organizations trying to counter these issues to increase mental health awareness and …

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness Read More »

New UCSF Research Program to Advance Psychedelics Research and Treatments

Leave a Comment / Education, Health & Performance, Psychedelics / By

Psychedelics research in support of brain health is getting a major boost this month with the formation of the Neuroscape Psychedelics Division at the University of California, San Francisco (UCSF). Through $6.4M in private funding, the new division will take a unique translational research approach to integrate cutting-edge neuroscience technology with psychedelics treatment, including through …

New UCSF Research Program to Advance Psychedelics Research and Treatments Read More »

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine

Leave a Comment / Education, Health & Performance, Psychedelics / By

ATMA and SYNTAC Institute Collaborate to Submit a Group Application for Section 56 Exemption from Health Canada to Access Psychedelic Therapy ATMA Journey Centers Inc. (ATMA), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians …

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine Read More »

A Review of Psychedelic Plant Medicine Studies in Canada

Leave a Comment / Education, Health & Performance, Plant Medicines, Psychedelics / By

Canada Plays a Significant Role in the Research of Natural Psychedelic Plant Medicine. The study of plant medicine and psychedelic plants gets a back seat when it comes to legal research and clinical trials. This is compared to the ease and simplicity of focusing on a psychedelic molecule, plant derivative, or a plant-based proprietary medicine, …

A Review of Psychedelic Plant Medicine Studies in Canada Read More »

Participate in a Mobile Microdose Study or Other Clinical Trials

Leave a Comment / Education, Health & Performance, Psychedelics / By

The Multidisciplinary Association for Psychedelic Studies (MAPS) in Canada, along with Quantified Citizen, a mobile health research platform, are launching the world’s first mobile study on the effects of microdosing psychedelic substances on cognitive performance and mental health. They are seeking both microdosers and non-microdosers who are over the age of majority, fluent in English, …

Participate in a Mobile Microdose Study or Other Clinical Trials Read More »